At 4.0% CAGR, the Europe DVT Preventive Pump Market is projected to be worth US$ 130.16 million by 2028, says Business Market Insights

According to Business Market Insights’ research, the Europe DVT preventive pump market was valued at US$ 102.99 million in 2022 and is expected to reach US$ 130.16 million by 2028, registering a CAGR of 4.0% from 2022 to 2028. Growing cases of cardiac disorders and stroke and significant flow in geriatric population and growing prevalence of deep vein thrombosis are the critical factors attributed to the Europe DVT preventive pump market expansion.

Over time, the healthcare industry is developing tremendously on a Europe level supported by government and non-government organizations and investments to ensure high-quality service and infrastructure for the increasing patient population, the There has been significant growth in chronic conditions such as cardiovascular disorders, orthopedic disorders, and cancer, along with the surge in trauma cases on the Europe level has increased surgical procedures. Additionally, the government and non-government organization have favorable reimbursement policies which are further expected to increase the number of surgical procedures. The surgery patients are more prone to DVT especially orthopedic surgery patients, as per the national library of medicine 2019 report, the incidence rate of postsurgical DVT in orthopedic patients is 7.2% which is doubled in patient aged 60 years and above. Therefore, the rising prevalence of DVT in surgery patients has increased the demand for effective preventive methods and DVT pumps is one of the most effective and efficient method without any side effects. Due to the reduced side effects and increased efficiency the DVT pumps are preferred by large patient population. Thus, the increase in surgical procedures and high adoption rate of DVT preventive pumps after surgeries are expected to create lucrative opportunities for DVT preventive pump market over the forecast period. This is expected to drive the Europe DVT preventive pump market during the forecast period.

On the contrary, absence of skilled professionals, side effects associated with pumps, and availability of alternatives hurdles the growth of Europe DVT preventive pump market. 

Based on type, the Europe DVT preventive pump market is bifurcated into lower extremity and upper extremity. The lower extremity segment held 67.4% market share in 2022, amassing US$ 69.45 million. It is projected to garner US$ 89.56 million by 2028 to expand at 4.3% CAGR during 2022–2028.

Based on end user, the Europe DVT preventive pump market is categorized into hospitals and clinics, surgical centres, and others. The hospitals and clinics segment held 41.0% of the Europe DVT preventive pump market share in 2022, amassing US$ 42.18 million. It is projected to garner US$ 55.17 million by 2028 to expand at 4.6% CAGR during 2022–2028.

Based on country, the Europe DVT preventive pump market has been categorized into Germany, the UK, France, Italy, Spain, and the Rest of Europe.  Our regional analysis states that the UK captured 27.6% of the Europe DVT preventive pump market share in 2022. It was assessed at US$ 28.43 million in 2022 and is likely to hit US$ 37.60 million by 2028, exhibiting a CAGR of 4.8% during the forecast period.            

Key players dominating the Europe DVT preventive pump market are Devo Medical Products Inc.; Breg Inc.; Cardinal Health Inc.; Arjo AB; Mego Afek Ltd.; DJO LLC; Zimmer Biomet Holdings Inc.; and Medcaptain Medical Technologies Co Ltd among others.

Contact Us
Phone: +16467917070
Email Id: sales@businessmarketinsights.com